Amardeep Singh, MD
Internal Medicine · Hattiesburg, MSNPI 1871120915
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $633, more than ten times the $25 reported in 2023.
Across 36 payments — averaging $25.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$179
- Pfizer$147
- Amgen$92
- AstraZeneca$90
- Lilly USA, LLC$90
- AbbVie$86
- plus $217 from 8 others
What the payments were for
- Food & beverage$901100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 8 | $179 |
| Pfizer | 3 | $147 |
| Amgen | 4 | $92 |
| AstraZeneca | 4 | $90 |
| Lilly USA, LLC | 4 | $90 |
| AbbVie | 3 | $86 |
| Exact Sciences | 3 | $70 |
| Boston Scientific | 1 | $26 |
| Dexcom, Inc. | 1 | $25 |
| Abbott | 1 | $24 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| BD | 1 | $17 |
| Agios Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ABRYSVO$101
How this compares
$901 in reported general payments places this provider in the 60th percentile of 846 internal medicine providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 35 | $192 |
| Metoprolol Succinate | 14 | $126 |
| ClopidogrelClopidogrel Bisulfate | 20 | $101 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $82 |
| Losartan Potassium | 13 | $59 |
| Amlodipine Besylate | 13 | $43 |
| Metformin Hcl | 11 | $42 |
| Furosemide | 11 | $21 |
| Prednisone | 13 | $13 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Hattiesburg
- Alexey FominHattiesburg$13K
- Quenyatta Echols-WilliamsHattiesburg$8K
- Charles HernandezHattiesburg$7K
- Kelly WilkinsonJackson$79K
- Shanna PettieJackson$53K
- Gabriel HernandezJackson$41K
- Indira VeerisettyRidgeland$25K
- James BridgesMadison$23K
- Brendan RossJackson$19K
- Hassan CheemaJackson$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.